1
40
1
-
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
July 2021 List
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
July 2021 List
URL Address
<a href="http://doi.org/10.1038/s41436-020-01067-9" target="_blank" rel="noreferrer noopener">http://doi.org/10.1038/s41436-020-01067-9</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Beyond diagnostic yield: prenatal exome sequencing results in maternal, neonatal, and familial clinical management changes
Publisher
An entity responsible for making the resource available
Genetics in Medicine
Date
A point or period of time associated with an event in the lifecycle of the resource
2021
Subject
The topic of the resource
Congenital anomalies; genetic condition; prenatal; Clinical management; exome sequencing
Creator
An entity primarily responsible for making the resource
Tolusso LK; Hazelton P; Wong B; Swarr DT
Description
An account of the resource
Purpose: Previous studies have reported that prenatal exome sequencing (pES) can detect monogenic diseases in fetuses with congenital anomalies with diagnostic yields ranging from 6% to 81%, but there are few reports of its clinical utility. Method(s): We conducted a retrospective chart review of patients who had pES to determine whether results led to clinical management changes. Result(s): Of 20 patients, 8 (40%) received a definitive diagnosis. Seven patients (35%) had medical management changes based on the pES results, including alterations to their delivery plan and neonatal management (such as use of targeted medications, subspecialty referrals, additional imaging and/or procedures). All patients who received a definitive diagnosis and one who received a likely pathogenic variant (n = 9; 45%) received specific counseling about recurrence risk and the medical/developmental prognosis for the baby. In five (25%) cases, the result facilitated a diagnosis in parents and/or siblings. Conclusion(s): pES results can have significant impacts on clinical management, some of which would not be possible if testing is deferred until after birth. To maximize the clinical utility, pES should be prioritized in cases where multiple care options are available and the imaging findings alone are not sufficient to guide parental decision-making, or where postnatal testing will not be feasible. Copyright © 2021, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1038/s41436-020-01067-9" target="_blank" rel="noreferrer noopener">10.1038/s41436-020-01067-9</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
2021
Clinical management
Congenital Anomalies
exome sequencing
genetic condition
Genetics in Medicine
Hazelton P
July 2021 List
prenatal
Swarr DT
Tolusso LK
Wong B